Prof. Philip Hawkins, FMedSci | oneAMYLOIDOSISvoice
×
Or register here
Global Search

Trusted Resources: People & Places

Healthcare providers, researchers, and advocates

Back to People / Healthcare Professionals
Prof. Philip Hawkins, FMedSci

Prof. Philip Hawkins, FMedSci

Healthcare Professional / Researcher
Clinical Director
Division of Medicine
University College London
Gower Street
London, United Kingdom
Prof. Philip Hawkins is a Professor of Medicine at University College London and Clinical Director of the NHS National Amyloidosis Centre at The Royal Free. He is a rheumatologist and clinical scientist renowned for his studies on amyloidosis. His seminal work includes development and implementation of serum amyloid P component (SAP) scintigraphy for diagnosis and quantification of systemic amyloidosis.
 
Philip Hawkins studied medicine at St. George’s Hospital Medical School, London where he qualified with distinction in 1982. After training in general internal medicine at St. George’s, he undertook specialist training in rheumatology at the Royal Postgraduate Medical School, Hammersmith Hospital where he subsequently obtained his PhD for studies on the pathogenesis and diagnosis of amyloidosis during a Medical Research Council Training Fellowship. 
 
Dr. Hawkin’s clinical research programme is focused on diagnosis, pathogenesis, monitoring and treatment of amyloidosis and inherited autoinflammatory diseases with an emphasis on translational, early phase and otherwise novel approaches. He has a particular interest in the development of new imaging methods.
 
 
Representative Publications:
 
 
view profile

Related Content

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close

Community Key Collaborator

Support for this landing page is provided by an independent education grant from

Translation of this platform made possible through an independent education grant from

© 2025 rareLife solutions Inc.

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close